Target intelligence / Profile preview

Vaginal epithelial cell barrier

Molecular classification
Other
01

Overview

The **vaginal epithelial cell barrier** refers to the multilayered stratified squamous epithelium of the vagina, which acts as a physical and immunological barrier protecting against microbial invasion and environmental threats. It undergoes dynamic hormone-dependent changes (especially estrogen-driven proliferation and cornification) and plays a crucial role in maintaining vaginal microbiota and homeostasis[1][2][3]. The most superficial layers are composed of dead, glycogen-filled cells that are loosely adherent, allowing some permeability to immune mediators but generally blocking most pathogens[2][3]. Barrier function depends on intercellular junctions in deeper epithelial layers and on antimicrobial peptides secreted locally[1][3]. Disruption of this barrier (by pathogens, inflammation, or hormonal shifts) can increase infection risk and compromise reproductive health[1][4]. The structure is influenced by, and reciprocally affects, the vaginal microbiome—especially Lactobacillus species, which maintain low pH and support barrier integrity[1][2][4]. **Note**: "Vaginal epithelial cell barrier" is an anatomical/functional structure—not a canonical molecular target like a receptor, ion channel, or enzyme. It is not the target of specific drugs in the classic sense, though several microbicide drugs and interventions act to protect or modulate its function[2][4]. Therefore, *is_target = false* and *is_incorrect = true* for purposes of molecular target mapping.

Other names
Vaginal epithelial barrierVaginal epitheliumVaginal mucosal barrier
02

Mechanism of action

Microbicide drugs: prevention of pathogen penetration and local antiviral/antibacterial activity

03

Biological functions

Barrier to infectionImmune responseMaintenance of mucosal homeostasisRegulation of microbial colonization
04

Disease associations

Infection (especially sexually transmitted infections)InflammationDysbiosis-associated conditions (such as bacterial vaginosis)Other (general involvement in mucosal and reproductive health)
05

Safety considerations

Barrier disruption: increases susceptibility to infectionInflammatory damage from chemical or infectious insultHormonal changes affecting barrier function
06

Interacting drugs

Topical microbicides (e.g., tenofovir, dapivirine rings)
07

Biomarkers

Barrier integrity (measured by electrical resistance or permeability)Presence of tight junction proteins (e.g., claudins, occludin, E-cadherin)Expression of antimicrobial peptides (beta-defensins, cathelicidins)Microbial metabolite (e.g., lactic acid) levels

Beyond the preview

Go deeper on Vaginal epithelial cell barrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal epithelial cell barrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call